Nondiabetic Kidney Disease

To the Editor: In his Clinical Practice article (Nov. 7 issue) 1 Dr. Levey states, “If an ACE [angiotensin-converting–enzyme] inhibitor is contraindicated because of cough or angioedema, then an angiotensin-receptor blocker would be a logical alternative.” Although an angiotensin-receptor blocker wo...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 348; no. 8; pp. 762 - 763
Main Author Pitts, David B
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 20.02.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To the Editor: In his Clinical Practice article (Nov. 7 issue) 1 Dr. Levey states, “If an ACE [angiotensin-converting–enzyme] inhibitor is contraindicated because of cough or angioedema, then an angiotensin-receptor blocker would be a logical alternative.” Although an angiotensin-receptor blocker would be a logical and safe alternative for someone with an ACE-inhibitor–related cough, the same cannot be said about someone who has previously had angioedema due to the use of an ACE inhibitor. There have been several reports of angioedema induced by the use of an angiotensin-receptor blocker in patients who had previously had angioedema while taking an ACE inhibitor. The . . .
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM200302203480820